Oxidative stress: A target to treat Alzheimer's disease and stroke

Seema Briyal, Amaresh K. Ranjan, Anil Gulati

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations

Abstract

Oxidative stress has been established as a well-known pathological condition in several neurovascular diseases. It starts with increased production of highly oxidizing free-radicals (e.g. reactive oxygen species; ROS and reactive nitrogen species; RNS) and becomes too high for the endogenous antioxidant system to neutralize them, which results in a significantly disturbed balance between free-radicals and antioxidants levels and causes cellular damage. A number of studies have evidently shown that oxidative stress plays a critical role in activating multiple cell signaling pathways implicated in both progression as well as initiation of neurological diseases. Therefore, oxidative stress continues to remain a key therapeutic target for neurological diseases. This review discusses the mechanisms involved in reactive oxygen species (ROS) generation in the brain, oxidative stress, and pathogenesis of neurological disorders such as stroke and Alzheimer's disease (AD) and the scope of antioxidant therapies for these disorders.

Original languageEnglish
Article number105509
JournalNeurochemistry International
Volume165
DOIs
StatePublished - May 2023
Externally publishedYes

Keywords

  • Alzheimer's disease
  • Antioxidant therapy
  • Brain disorders
  • Endothelin B receptors
  • Endothelins
  • Oxidative stress
  • Sovateltide
  • Stroke

Fingerprint

Dive into the research topics of 'Oxidative stress: A target to treat Alzheimer's disease and stroke'. Together they form a unique fingerprint.

Cite this